Your browser doesn't support javascript.
loading
Tyrosine kinase inhibitors induce mesenchymal stem cell-mediated resistance in BCR-ABL+ acute lymphoblastic leukemia.
Mallampati, Saradhi; Leng, Xiaohong; Ma, Haiqing; Zeng, Jianfang; Li, June; Wang, Haiying; Lin, Kevin; Lu, Yue; Yang, Yang; Sun, Baohua; Gong, Yun; Lee, Ju-Seog; Konopleva, Marina; Andreeff, Michael; Arlinghaus, Ralph B; Cai, Zhen; Fang, Bingliang; Shen, Haifa; Han, Xin; Hirsch-Ginsberg, Cheryl F; Gao, Xiaolian; Paranjape, Anurag N; Mani, Sendurai A; Clise-Dwyer, Karen; Sun, Xiaoping.
Afiliação
  • Mallampati S; Department of Laboratory Medicine and the Center for Stem Cell and Developmental Biology, and.
  • Leng X; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX;
  • Ma H; Department of Laboratory Medicine and the Center for Stem Cell and Developmental Biology, and Department of Oncology, The Fifth Affiliated Hospital of Sun Yat-sen University, Zhuhai, China;
  • Zeng J; Department of Laboratory Medicine and the Center for Stem Cell and Developmental Biology, and.
  • Li J; Department of Laboratory Medicine and the Center for Stem Cell and Developmental Biology, and.
  • Wang H; Department of Laboratory Medicine and the Center for Stem Cell and Developmental Biology, and Department of Hematology, The Affiliated Hospital of Weifang Medical University, Weifang, Shandong, China;
  • Lin K; Department of Molecular Carcinogenesis, The University of Texas MD Anderson Cancer Center, Houston, TX;
  • Lu Y; Department of Molecular Carcinogenesis, The University of Texas MD Anderson Cancer Center, Houston, TX;
  • Yang Y; Department of Laboratory Medicine and the Center for Stem Cell and Developmental Biology, and Multiple Myeloma Treatment Center and Department of Hematology, The First Affiliated Hospital of Medical College, Zhejiang University, Hangzhou, Zhejiang, China;
  • Sun B; Department of Laboratory Medicine and the Center for Stem Cell and Developmental Biology, and.
  • Gong Y; Department of Pathology.
  • Lee JS; Department of System Biology.
  • Konopleva M; Department of Leukemia, Department of Stem Cell Transplantation, and.
  • Andreeff M; Department of Leukemia, Department of Stem Cell Transplantation, and.
  • Arlinghaus RB; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX;
  • Cai Z; Multiple Myeloma Treatment Center and Department of Hematology, The First Affiliated Hospital of Medical College, Zhejiang University, Hangzhou, Zhejiang, China;
  • Fang B; Department of Thoracic and Cardiovascular Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX;
  • Shen H; Department of Nanomedicine, Houston Methodist Research Institute, Houston, TX; Department of Cell and Developmental Biology, Weill Cornell Medical College, New York, NY; and.
  • Han X; Department of Laboratory Medicine and the Center for Stem Cell and Developmental Biology, and.
  • Hirsch-Ginsberg CF; Department of Laboratory Medicine and the Center for Stem Cell and Developmental Biology, and.
  • Gao X; Department of Biology and Biochemistry, University of Houston, Houston, TX.
  • Paranjape AN; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX;
  • Mani SA; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX;
  • Clise-Dwyer K; Department of Stem Cell Transplantation, and.
  • Sun X; Department of Laboratory Medicine and the Center for Stem Cell and Developmental Biology, and.
Blood ; 125(19): 2968-73, 2015 May 07.
Article em En | MEDLINE | ID: mdl-25712988

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteínas de Fusão bcr-abl / Resistencia a Medicamentos Antineoplásicos / Inibidores de Proteínas Quinases / Leucemia-Linfoma Linfoblástico de Células Precursoras / Células-Tronco Mesenquimais Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Revista: Blood Ano de publicação: 2015 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteínas de Fusão bcr-abl / Resistencia a Medicamentos Antineoplásicos / Inibidores de Proteínas Quinases / Leucemia-Linfoma Linfoblástico de Células Precursoras / Células-Tronco Mesenquimais Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Revista: Blood Ano de publicação: 2015 Tipo de documento: Article